Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type
| Autor: | Lephart, Paul R., Bachman, Michael A., LeBar, William, McClellan, Scott, Barron, Karen, Schroeder, Lee, Newton, Duane W. |
|---|---|
| Zdroj: | In Diagnostic Microbiology & Infectious Disease January 2021 99(1) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect